Mutation of four arginine residues in P34 leads to a decrease in binding between P34 and L5. by Anyango D. Kamina (4034165)

Coibamide A induces a time- and concentration-dependent decrease in plasma membrane integrity. by Andrew M. Hau (418935)

NG2 knockdown in GBM xenografts increased vascular reabsorption, decreased plasma volume and normalized tumour vasculature. by Jian Wang (5901)

<i>Vps13</i> mutant flies show a decreased life span, age dependent impairment of locomotor function and neurodegeneration. by Jan J. Vonk (3686662)

Inhibition of ABCG2 decreases SP cells, but not sphere-forming ability. by Noriko Kawai (6694010)

MEK5 expression decreases ER signaling and confers endocrine resistance. by James W. Antoon (444010)

TGF-β₁ increases proliferation but decreases AP activity in cultured osteoblasts. by Sabrina Ehnert (359631)

“…<p>Primary human osteoblasts were treated for 8 days with different conc. (0, 1, 2.5, 5, 10 ng/ml) of hra TGF-β₁. (A) SRB staining of surface proteins showed that TGF-β₁ dose-dependently increased proliferation of osteoblasts. …”

Cobalt decreases the expression of AQP5 expression in MLE-12 cells. by Jitesh D. Kawedia (384551)

Excision of HIF1α decreases viral reactivation from latency in infected splenocytes in vivo. by Darlah M. López-Rodríguez (8098544)

Overexpression of NPY induces obesity and decreases glucose utilization in adipose tissue. by Min Long (397430)

c-Yes knock-down increases apoptosis and decreases growth in soft-agar and in mouse xenografts. by Florence Sancier (229473)

Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

Subjects:

IL-7 decreases apoptosis of HIV-1-infected CD4⁺ T cells. by Andrea Introini (284643)

ShakB(N+16) increases, and ShakB(N) decreases, NB coupling. by Sami H. Jezzini (650703)

HC-070 decreases anxiety after CCK-4 treatment in an EPM. by Stefan Just (4811358)

Mutations in inverted DNA repeats in P_<i>ganS</i> decrease GanR binding. by Cameron Habib (4112590)

Loss of <i>SLC4A11</i> expression in hCEnC leads to decreased cell barrier function. by Doug D. Chung (3611387)

HRMECs treated with 3-Deazaneplanocin A (DZNep) chemical inhibitor demonstrated increased miR-200b and decreased VEGF expression. by Michael Anthony Ruiz (726055)

“…[NG = 5mM D-glucose, HG = 25mM D-glucose, NG+DMSO = 5mM D-glucose + 0.05% DMSO, HG+DMSO = 25mM D-glucose + 0.05% DMSO, NG+DZNEP = 5mM D-glucose + 5μM DZNep, HG+DZNEP = 25mM + 5μM DZNep; identical letters represent groups that are not significantly different; p < 0.05; n = 6; data expressed as mean ± SEM, normalized to β-actin for VEGF and U6 for miR-200b, expressed as a fold change of NG].…”

AnxA5 results in a tendency to decrease the monocyte endothelium interaction in a flow model. by Robert Stöhr (3583700)

Decreased reductase activity and increased round body formation in the <i>gpsA</i> mutant. by Dan Drecktrah (36180)